Introduction
Six virus-encoded nuclear antigens (EBNAs) I to 6 (Dillner & Kallin, 1988) and three membrane proteins, LMP-1 (Fennewald et al., 1984) , LMP-2A and LMP-2B are expressed in Epstein-Barr virus (EBV)-immortalized lymphoblastoid cell lines (LCLs). The two main EBV-associated human tumours, Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC) differ from LCLs with regard to the expression of these antigens. BL biopsies and recently established BL lines (group I BLs) express EBNA-1 only (Ricksten et al., 1988; Rowe et al., 1986) . NPC biopsies express EBNA-I and, in 65% of cases, also LMP (F~hraeus et al., 1988) .
Expression of the transformation-associated EBV antigens in LCLs correlates with the expression of B blast markers, such as CD23 and CD39 (Calender et al., 1987; Thorley-Lawson & Mann, 1985) . In contrast, EBV-carrying BL cells resemble resting B cells rather than activated blasts (Nilsson & Klein, 1982) . They are CD23-and CD39-negative, and express the germinal centre markers CD10 and CD77 (Ehlin-Henriksson & Klein, 1984; Nudelman et al., 1983) . BL lines can drift to a more 'LCL-like' phenotype, with regard to EBV antigens and surface marker expression, during serial in vitro passage (Rowe et al., 1987) . The differential expression of EBNAs 1 to 6 and LMP-1 in EBV-carrying ceils is entirely dependent on the host cell phenotype. This is illustrated by the fact that rescue of the virus from BLs and NPCs into normal B cells is accompanied by the full expression of all seven proteins in the derived LCLs Lozzio & Lozzio, 1975; Rowe et al., 1986) .
Some information is emerging on the mechanisms that regulate the expression of viral antigens in different types of EBV-carrying cells. In virally immortalized LCLs and in BL lines which have drifted to an 'LCL-like' phenotype, transcription of EBNAs can be initiated from one of two promoters located in BamHI C (Bodescot et al., 1986) and in BamHI W (Sample et al., 1986; Speck et al., 1986) , generating a single precursor of approximately 85 kb (Woisetschlaeger et al., 1989) . Messages encoding the individual EBNA proteins are generated from this primary mRNA by differential splicing. Type I BL cells that express only EBNA-1 utilize neither the BamHI W nor the BamHI C promoter for the expression of EBNA-1 (Altiok et al., 1991; Jansson et al., 1991 ; Sample et al., 1991) . The BamHI W promoter was also silent in a nude mouse-propagated NPC (Hittet al., 1989) . EBNAs 2 to 6 have been detected only in B cell-derived lines. Ricksten et al. (1988) have shown that transcriptional factors required for the activity of the BamHI W enhancer are present in the EBV-negative BL DG75 but not in HeLa cells. This restricted expression of transcription regulatory factors may account for the B cell specificity of EBNAs 2 to 6. EBNA-2 appears to be required tbr LMP-1 expression in B cells. Expression of high levels of EBNA-2 was shown to override the activity of a negative regulatory element located in the 5' flanking region of the LMP-1 gene (LRS) (Ffihraeus et al., 1990) . This negative regulation appears to prevail in BL cells (R. Ffihraeus et al., personal communication) . Previous studies on somatic cell hybrids between EBV-carrying and EBV-negative B cell lines, and EBV-converted sublines of the latter, have identified two further examples of LMP-1 control. The BL line Ramos is non-permissive for LMP-1, even if EBNA-2 is present, whereas the B lymphoma (nonBurkitt) line B JAB is permissive for LMP-1 even in the absence of EBNA-2 (Contreras- Salazar et al., 1989) . EBNA-2-independent expression of LMP-1 has been found also in NPC cells (Ffihraeus et al., 1988) .
These findings suggest that different mechanisms control the expression of the growth transformationassociated EBV antigens EBNA-1, EBNAs 2 to 6 and LMP-1, respectively. To examine the validity of this notion, additional phenotypes need to be tested. It has been demonstrated that when B cells are fused with non-B cells, B cell markers and immunoglobulin production are regularly eclipsed (Bergman et al., 1990; Junker et al., 1990; Tripputi et al., 1988) . This provides a special opportunity to test the B cell phenotype dependence of EBNAs 2 to 6 expression, in contrast to the apparent independence of EBNA-1 and relative independence of LMP-1. Therefore we have examined a series of somatic cell hybrids derived from the fusion of LCL and BL cells with cell lines of epithelial, fibroblast, erythroid and myeloid origin. We have found that EBNAs 2 to 6, but not EBNA-1, are down-regulated in parallel with suppression of the B cell phenotype. We have also confirmed that LMP-1 can be expressed independently of EBNA-2 in hybrids with a dominating epithelial phenotype.
Methods
Cell lines and hybrids. The origin and characteristics of the cell lines and hybrids used in this study are shown in Table 1 . All the lines were maintained in RPMI supplemented with 10% foetal calf serum (FCS). The 6-thioguanine-and ouabain-resistant (6-TG r/oua r) LCL KR-4 was kept in 3 ~tg/ml of 6-thioguanine and 10-4M-ouabain. All hybrid lines expressed EBNA in 100% of the cells as detected by anticomplement immunofluorescence (ACIF) staining (Reedman & Klein, 1973) . The KH hybrids were obtained by fusing KR-4 with HeLa cells in the presence of 50% (w/v) polyethylene glycol, M, 1500 (Sigma P-7777). Two adherent colonies designated KH-I and KH-2 were isolated after selection on HAT and ouabain-containing medium. They were morphologically similar to HeLa cells and expressed EBNA in 100% of the cells.
Detection ofEBV genomes. Total DNA from the KH-I and KH-2 hybrids and their parental lines was prepared by standard procedures (Sambrook et al., 1989) . Ten to 20~tg of DNA was cleaved with 6 units/~tg DNA of the restriction enzyme BamHI (Amersham) and separated in a 0.75% agarose gel in Tris borate-EDTA buffer (TBE) for 14 h at 40 V. The DNA was denatured and transferred to nylon filters (Hybond-N, Amersham) as described (Southern, 1975) . Prehybridization was carried out in 6 × SSPE, 1% SDS, 100 ~tg/ml salmon sperm DNA (Boehringer-Mannheim) and 10 × Denhardt's solution at 42 °C overnight. BamHl-cleaved total EBV DNA or a 3.1 kb XhoI XhoI fragment from the EBV Eco Dhet region containing the viral terminal repeats (provided by L. Rymo, University of Gothenburg, Sweden) were used as probes.
[3zp]dCTP (Amersham) labelling was performed by random primer oligolabelling. Hybridization was performed at 42 °C for 16 h in a solution containing 6 × SSPE, 100 rtg/ml salmon sperm DNA, 50% formamide, 1% dextran sulphate and the radioactive probe. The filters were washed for 15 min in 2 × SSPE 0.1% SDS at room temperature twice for 30 min in 0.2 × SSPE-0.1% SDS at 65 °C and 5 rain in 0.1% SSPE. They were then exposed to Fuji X-ray films for 24 to 48 h at -70 °C and developed.
Detection oJ EB V antigens
(i) lmmunofluorescence. The EBNA complex was detected by ACIF staining (Reedman & Klein, 1973) using the human serum KF (with antibody titres against EBNA l, 1:320; EBNA 2, 1:160; EBNA 6, 1 : 160; VCA, 1 : 320; EA, 1 : 20). The same serum was rendered specific for EBNA-2 by absorption with P3HR-1 cells that carry an EBNA-2-deleted viral substrain (Bornkamm et al., 1980) as previously described (Dillner et al., 1985) . The specificity was confirmed by ACIF staining of EBNA-I-to EBNA-6-transfected DG75 (data not shown). The monoclonal antibody (MAb) PE-2 (provided by L. Young, CRC laboratories, Birmingham University, U.K.) was also used as a monospecific reagent for EBNA-2.
(ii) lmmunoblotting. Total cell extracts from the cell hybrids and parental lines were separated by SDS-PAGE according to the method of Laemmli (1970) and blotted onto nitrocellulose filters (Schleicher & Schfill, no. 401196) as previously described (Towbin et al., 1979) . The filters were incubated for 2 h at room temperature in PBS containing 5% dried skimmed milk. To detect EBV proteins the filters were incubated overnight at 4 °C with: (i) a 1:50 dilution of the human serum PG with antibody titres against EBNA-I (1:320), EBNA-2 (1:320), EBNA-6 (1:320), VCA (1:20480), EA (1:2560); (ii) a 1:50 dilution of the anti-EBNA-2 MAb PE-2; (iii) a 1:1000 dilution of the anti-LMP-1 MAb S-12 (provided by D. Thorley-Lawson, Tufts University, Boston, Mass., U.S.A.) The protein-antibody complexes were reacted with alkaline phosphatase-eonjugated anti-human or antimouse second antibodies (Bio-Rad) and visualized by fast red salt precipitation in the presence of ct-naphthyl phosphate (Sigma).
Surface cell markers. Fluorescence activated cell sorter analysis was performed on cells stained by indirect immunofluorescence with the following MAbs: J55 (CD10) (Ritz et al., 1980) and 38.13 (CD77) (Wiels et al., 1981) which are BL cell markers also present in a subpopulation of germinal centre blasts; B1 (CD20) (Stashenko et al., 1980) and B4 (CD19) (Nadler et al., 1983) which recognize pan-B cell markers; LB-1 (CD39) (Yokochi et al., 1982) which is expressed on 
Results

Cell hybrids
The Dutko (Zeuthen et al., 1982) , Putko (Klein et al., 1980) , HP-1 (Koeffler et al., 1981) and A9HT-Raji hybrids were established in this laboratory and have been characterized extensively. The KH-1 and KH-2 clones, derived from the fusion of KR-4 and HeLa ceils, and morphologically similar to the HeLa cells, were isolated after selection in HAT and ouabain-containing medium. The two clones were 100% EBNA-positive as assessed by ACIF staining with the KF serum. They had mean chromosome numbers of 70.4 and 71.4 respectively. The parental KR-4 line contains an average of 45.6 chromosomes whereas HeLa has a mean chromosome number of 71.5. Immunoglobulin gene rearrangement and restriction fragment length polymorphism analysis of chromosome 2 (Igx chains), 22 (Ig light chains) and chromosome 14 (Ig heavy chains) showed that both clones contain chromosomes 14 and 22, a rearranged immunoglobulin gene from the KR-4 parental chromosome 2, and an unarranged immunoglobulin gene from the HeLa cell line (data not shown).
The hybrids KH-1 and KH-2 were tested for the presence of EBV DNA by probing Southern blots of total BamHI-digested DNA with EBV probes. The pattern of bands detected by hybridization with 32p-labelled total EBV DNA was identical in KH-1, KH-2 and KR-4 (Fig.  1) . Comparison of the intensity of the EBV-specific bands suggests that the EBV copy number is lower in the hybrids than in the parental line. The two hybrids carried the same terminal repeat fusion fragments as KR-4 (Fig.  2) . This shows that the viral genomes carried by the hybrids were derived from the same circularization event as the parental line and that no infectious cycle had intervened.
Expression of B cell markers and major histocompatibility complex ( MHC)-associated antigens
Phenotypic characterization of the cell hybrids and parental lines is shown in Table 2 . The pan-B cell markers CD19 and CD20 were expressed on the B cell parental lines P3HR-1, Daudi, Raji and KR-4. They were not expressed on the non-B cell parents K562, A9HT and HeLa. Some reactivity was observed with the HL-60 myeloid leukaemia line. Of the five hybrids tested, only HP-1 expressed CD19 and CD20 at the same level as the B cell parent. CD21 was expressed in Raji and Daudi BL lines. It was detected at very low levels in KR-4. CD21 antigens were down-regulated in the Dutko hybrid. An increase in CD21 expression was observed in KH-1 and KH-2 hybrids.
Two BL-associated markers, CD10 (CALLA) and CD77 (BLA), were studied. The anti-CD10 MAb reacted with the BL parents and with HL-60 and K562. Only a minority of KR-4, A9HT and HeLa cells were weakly stained. HP-1 was the only hybrid that maintained the strong reactivity of the BL parent as compared with the low reactivity of the other P3HR-1 hybrid Putko. CD10 expression was turned off in the Dutko and A9HT-Raji hybrids, it was increased at marginal levels in the KH-1 and KH-2 hybrid clones. CD77 was present in the BL lines P3HR-1 and Daudi. Fusion of either of them with the erythroleukaemia line K562 (Putko and Dutko hybrids) resulted in the extinction of CD77 expression. antigens were not detected in the Putko hybrid and were expressed only at a low level in Dutko. The HP-1, KH-1 and KH-2 hybrids expressed class I antigens at the same level as their parental lines. The A9HT-Raji hybrid cells did not react with the W6/32 MAb. MHC class II antigens and surface or cytoplasmic immunoglobulin were expressed on all the B cell parents. Only HP-1 maintained HLA class II and Ig expression among the hybrids analysed. Both markers were eclipsed in Putko, Dutko, A9HT-Raji, KH-1 and KH-2 hybrids. The reactivity of the HP-1 hybrid was intermediate between that observed in the P3HR-I and HL-60 parental lines.
The activation markers CD39 and CD23 were expressed at a high level in the KR-4 LCL and downregulated in the KH-1 and KH-2 hybrids (Table 2) .
MHC class I antigens were assessed by staining with the anti-framework antibody W6/32; HLA class I was not detected in the murine A9HT line nor in Daudi and K562, which have previously been shown to be defective for these molecules (Klein et al., 1977 (Klein et al., , 1980 . HLA class I
Expression of EB V antigens
The expression of EBNAs 1 to 6 and LMP-1 was studied by immunofluorescence and immunoblotting.
EBNA-1 was the only viral antigen among the seven studied that was consistently expressed in all the hybrids (Fig. 3) . The EBNA-l-specific band showed the characteristic size variation which is typical for the virus strains carried by the different EBV-positive cells.
EBNA-2 was not expressed in Daudi and P3HR-1 cells owing to known deletions in the EBNA-2 encoding region. The faint band observed in the EBNA-2 region in the P3HR-1 BL cells (Fig. 3) is probably due to the reactivity of the PG serum against a protein of similar Mr since we failed to detect EBNA-2 by monospecific reagents on Western blots (Fig. 4) or by immunofluorescence (data not shown). EBNA-2 was expressed at high levels in Raji and in KR-4 cells. It was not detected in the A9HT-Raji, KH-1 and KH-2 hybrids (Fig. 3) . The lack of EBNA-2 expression was also corroborated by probing the blots with the EBNA-2-specific MAb PE-2 (Fig. 4) . The band observed in the EBNA-2 region in the blot presented in Fig. 4 is a non-specific band detected by the S-12 MAb which was used together with the PE-2. The expression/down-regulation of EBNA-2 was corroborated by immunofluorescence with the absorbed human serum KF (not shown). (4) 68 (24) 90 (11) 70 (2) 18 (9) 6 (7) 1 (1) 3 (1) 53 (6) 3 (1) CD20 67 (8) 67 (17) 76 (20) 84 (8) 19 (4) 3 (4) 2 (3) 1 (1) 53 (5) 3 (2) CD21 0 (1) 18 (17) 52 (2) 5 (4) ND~ 7 (6) ND 1 (1) 1 (0) 4 (3) Germ C § CDI0 87 (3) 81 (10) 76 (28) 15 (5) 64 (14) 54 (16) 13 (12) 8 (4) 83 (11) 27 (33) CD77 85 (2) 46 (38) 9 (9) 2 (3) 13 (14) 3 (4) 30 (6) 47 (4) 27 (20) 4 (2) Act[I CD39 8 (7) 24 (26) 10 (14) 90 (1) 3 (4) 7 (5) 3 (3) 1 (1) 17 (19) 4 (2) CD23 0 (0) 1 (1) 55 (7) 71 (1) ND 3 (2) ND 8 (1) 7 (1) 2 (2) MHC Class I 59 (59) 11 (8) 95 (3) 94 (4) 89 (9) 12 (17) 4 (2) 88 (4) 89 (3) 7 (6) Class II 61 (61) 87 (1) 96 (4) 95 (5) 39 (36) 6 (8) 3 (3) 4 (4) 78 (22) 13 (8) 13 (18) 28 (20) 2 (0) 9 (7) 30 (26) 2 (I) 4 (3) 3 (1) 0 (1) ND 1 (2) 42 (7) 6 (5) 91 (4) 4 (2) 6 (3) 10 ( 3 . Expression of EBNAs (E) 1 to 6 in B-non-B cell hybrids. Immunoblots were performed as described in Methods and probed with the human serum PG absorbed with a cell pellet of non-B cell lines to eliminate background. Dutko (Daudi-K562); Putko (P3HR-1-K562); HP-1 (P3HR-1-HL-60); KH-1 and KH-2 (KR-4-HeLa). Lanes: 1, K562; 2, Daudi; 3, Dutko; 4, P3HR-1 ; 5, Putko; 6, HP-I ; 7, KR-4; 8, HeLa; 9, KH-1; 10, KH-2; 11, Raji; 12, A9HT; 13, A9HT-Raji; 14, B95-8.
E B N A s 3 to 6 w e r e e x p r e s s e d at h i g h levels in the K R -4 a n d at l o w e r levels in the B L lines Raji, P 3 H R a n d D a u d i . E B N A s 3 to 6 w e r e n o t d e t e c t e d in the D u t k o , P u t k o , K H -I , K H -2 a n d A 9 H T -R a j i hybrids. T h e H P -1 h y b r i d e x p r e s s e d E B N A s 3, 4 a n d 6 at the s a m e level as the p a r e n t a l line P 3 H R -1 (Fig. 3) . E B N A 5 was d e t e c t e d in n o n e o f the h y b r i d s a n d p a r e n t a l lines by using the J F -186 M A b (data n o t shown).
L M P -1 was not e x p r e s s e d in D a u d i cells. It was e x p r e s s e d at a low level in P 3 H R -1 cells a n d at a h i g h level in Raji and KR-4 cells (Fig. 4) . LMP-1 was expressed in the HPI hybrid at the same level as in the parental P3HR-1, and in the KH-1 and KH-2 hybrids. The remaining hybrids were LMP-l-negative.
Discussion
The three best known EBV-carrying cell prototypes LCL, BL (group I) and NPC differ in their EBV antigen expression. All of them express EBNA-1. Only B blasts (LCLs or BLs that have drifted to an 'LCL-like' phenotype) express EBNAs 2 to 6. LMP-1 can be expressed in NPC cells in the absence of EBNA-2, but its expression is dependent on EBNA-2 in most of the B cell lines examined. The P3HR-1 cell line that is included in this study is the only reported exception to this rule. The results presented in this paper confirm this and provide some additional clues to the differential regulation of these proteins. We have shown that extinction of B cell markers CD19, CD20, HLA class II antigens, and immunoglobulin expression is associated with a selective downregulation of EBNAs 2 to 6 after fusion of EBV-carrying LCL or BL cells with non-B cell lines. This was particularly evident in the KH-1 and KH-2 hybrids, derived by the fusion of the KR-4 LCL with HeLa cells, and in the A9HT-Raji hybrids. The antigens were strongly expressed on the B cell parents but could not be detected in the hybrids, either by immunoblotting or by immunofluorescence. EBNA-2 expression could not be studied and the Daudi-and P3HR-l-derived hybrids due to the deletion of the EBNA-2 gene (Bornkamm et al., 1980; Jones et al., 1984) . P3HR-1 and Daudi cells express low levels of EBNAs 3, 4 and 6, however. All three antigens were eclipsed in Putko and Dutko hybrids in parallel with loss of the B cell markers, but were maintained in the HP-1 hybrid that retained the B cell phenotype. The comparison between the Putko and HP-1 hybrids is particularly informative. It has been shown previously that the K562 phenotype is dominant in the Putko hybrid (Klein et al., 1980; Zeuthen et al., 1982) whereas HP-I maintains the B cell markers, MHC class II and cytoplasmic Ig expression of P3HR-1 cells (Koeffler et al., 1981) . The mechanism of this B cell phenotype-dependent expression of EBNAs 2 to 6 is not known. Reporter plasmids carrying the chloramphenicol acetyl transferase gene under the control of the BamHI W (Ricksten et al., 1988) and BamHI C promoters (L. Rymo, personal communication) are active only in B cells, suggesting that B cell-specific transcription regulatory factors might be required. The loss of these factors in cell hybrids expressing a non-B cell phenotype could explain the parallel down-regulation of EBNAs 2 to 6 since the mRNAs of these four proteins all start from the same promoters. A similar mechanism appears to explain the loss of immunoglobulin gene expression in B cell-fibroblast hybrids. Bergman et al. (1990) and Junker et al. (1990) have shown that the OTF-2a and OTF-2b transcription regulatory factors, which bind to the octamer motifs of the Ig heavy chain promoter and enhancer, are not expressed in somatic cell hybrids between B and non-B cells. Transfection of an OCT-2 expression vector was sufficient to activate an octamercontaining reporter plasmid and a stably integrated Ig promoter construct (Junker et al., 1990) .
In contrast to EBNAs 2 to 6, EBNA-1 was regularly expressed in the cell hybrids. The antigen was detected by ACIF staining in 100~ of the cells, but the level of expression was significantly lower in the hybrids than in the parental EBV-positive lines (Fig. 3) . This could be due to a relatively lower number of viral episomes. Comparison of the EBV DNA-specific bands in the KH-I, KH-2 and KR-4 cell lines (Fig. 1) suggests that the EBV copy number could be as much as 10 times lower in the hybrids compared to the parental line. It is unlikely that this is sufficient to explain the low EBNA-1 expression; however, cell lines like Namalwa, IB-4 and in vitro EBV-converted BL lines that carry only a single integrated EBV genome (Hurley et al., 1989; Matsuo et al., 1984) can express EBNA-1 at a level comparable to LCLs that carry multiple copies. The lower expression of EBNA-1 may reflect a different mode of regulation in the hybrids compared to the parental lines. It is noteworthy that EBNA-1 is also expressed at a lower level in NPC biopsies and group I BLs compared to LCLs (Gregory et al., 1990; and unpublished observations) . In EBVtransformed LCLs and BLs that have shifted towards an 'LCL-like' phenotype, the mRNAs of all six EBNAs including EBNA-1 are spliced from the same primary transcript, initiated at either the BamHI C or BamHI W promoter. These promoters were shown to be transcriptionally silent in NPCs and group I BL cells (Hitt et al., 1989; Janson et al., 1991; Sample et al., 1991) . This suggests that a switch from an as yet unidentified EBNA-1-specific promoter to the C or W promoter may take place when BL cells drift to a more LCL-like phenotype. The putative EBNA-1 promoter must be subject to a more permissive mode of regulation, since loss of EBNA-1, which has been shown to be required for episomal maintenance (Yates et al., 1985) could result in the loss of the viral genome.
The down-regulation of EBNAs 2 to 6 that occurs in parallel with the eclipse of B cell markers in B/non-B cell hybrids provides a mirror image of the up-regulation that occurs during the group I to group III phenotype drift in BL cells. Somatic cell hybrids may therefore provide an additional model to study the mechanism controlling the usage of different viral promoters in EBV-infected cells.
Our results confirm the notion, based on the analysis of NPC biopsies and nude mouse-propagated tumours (F~hraeus et al., 1988) , that LMP-1 can be expressed independently of EBNA-2 in epithelial cells. LMP-1 was expressed in the KH-1 and KH-2 hybrids that had a HeLa phenotype but not in A9HT-Raji and in Putko hybrids that resembled the fibroblast and erythroleukaemia parents, respectively, suggesting that the aforementioned cell types may provide an LMP-1 non-permissive environment. F~hraeus et al. (1990) have recently shown that the 5' region of the LMP-1 gene contains sequences that respond to a negative regulatory element in the EBV-negative BL line DG75. EBNA-2 overrides this restriction either by direct interaction with the LMP-1 regulatory sequence, or indirectly by modifying the activity of a transcriptional repressor. It is tempting to speculate that the same type of negative regulation may prevail in the fibroblast and erythroid cell phenotypes. 
